Illumina’s Market Dominance Faces New Test As Roche Plans 2026 Sequencer Launch

As Roche prepares to intensify competition, CEO Jacob Thaysen says Illumina’s multidimensional performance will keep it ahead.

During its third-quarter earnings call on Oct. 30, Illumina CEO Jacob Thaysen said that competition remains a positive force for the company. Picture Courtesy: Shutterstock

More from Strategy

More from Business